Based on Bitcoin's current price of about $68,000, that would represent nearly a 200% gain. As a result, billionaire ...

The underperformance of the small-cap Russell 2000 stems from being heavily weighted towards biotech companies, most of which ...

The following nine long-term stocks stand out to us thanks to the weight of their fundamentals and not just the latest headlines or social media buzz.

Analyst Brendan Smith of TD Cowen maintained a Buy rating on Evotec AG (EVO – Research Report), with a price target of $10.00. Brendan ...

Shares MSCI India ETF offers exposure to India's booming economy. Find out why INDA is a cautious buy after a 10% pullback, ...

For perspective, Broadcom's done just under $47 billion worth of business over the past four reported quarters.

("Gannett", "we", "us", "our", or the "Company") (NYSE: GCI) today reported its financial results for the third quarter ended September 30, 2024. "We continued to make solid progress on our key ...

In a report released yesterday, Colin Langan from Wells Fargo maintained a Hold rating on AutoNation (AN – Research Report), with a price ...

Welcome to the Moderna third quarter 2024 conference call. [Operator instructions] Please be advised today's conference is ...

Even if the streaming business model doesn’t further evolve, Max’s content and existing scale make it one of the few platforms that can stand alone and still attract ... regarding how consumers ...

Viking Therapeutics shows significant clinical progress in obesity and NASH. Learn more about VKTX stock and its potential ...

would steep increases in demand for its primary products have provided the opportunity for it to restore profitability as a stand-alone business. However, the depths of the manufacturing and ...